ABT vs MLP · P/E 25, rev $44.33B vs rev $11.6M
Abbott Laboratories (ABT) versus Maui Land & Pineapple Company Inc (MLP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Maui Land & Pineapple Company Inc (MLP) is a real estate services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported MLP revenue for 2024-12-31 was $11.6M. Net income was -$7.4M. Revenue was up 24.5% from 2023-12-31 to 2024-12-31. MLP currently screens at market cap $353.6M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. MLP currently screens at market cap $353.6M.
Not investment advice. Open the ABT and MLP stock pages for the full models.
Not investment advice.